Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
Κύριοι συγγραφείς: | Jayne, DR, Rasmussen, N |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1997
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
ανά: Rohini Handa
Έκδοση: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
ανά: John Chuan Nguyen Tran, κ.ά.
Έκδοση: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
ανά: Flossmann, O, κ.ά.
Έκδοση: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
ανά: Brendan L. Thoms, κ.ά.
Έκδοση: (2021-07-01)